Live symbol workspace

PACB market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $1.34

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$1.27

Resistance

$1.41

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$1.34

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

33%

▲ 3.0 pts vs previous week

Avg confidence across 10 calls in the last 7 days

What sources say

Bullish 1 article

Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why

Insider Trading

Insider	Role	Date	Type	Value
Gibson James R …	See Remarks	Apr 01 '26	Sale	120813.0
JAMES GIBSON	Officer	Apr 01 '26	Proposed Sale	120778.0
HENRY CHRISTIAN O	See Remarks	Mar 03 '26	Sale	18920.0
Van Oene Mark	See Remarks	Mar 03 '26	Sale	9847.0
Farmer Michele	See Remarks	Mar 03 '26	Sale	4510.0
MARK D. VAN …	Officer	Mar 03 '26	Proposed Sale	9849.0
CHRISTIAN HENRY	Officer	Mar 03 '26	Proposed Sale	18924.0
Van Oene Mark	See Remarks	Feb 17 '26	Sale	204549.0
Van Oene Mark	See Remarks	Feb 18 '26	Sale	89769.0
HENRY CHRISTIAN O	See Remarks	Feb 17 '26	Sale	522906.0

Source: FinViz — Data may be delayed

Technical Observations

Refreshing technical observations from FinViz...

PACB News Intelligence (2 articles)

AI-curated news influencing PACB price, sentiment, and trend

Explore All PACB News with AI Analysis

Economy

3 days, 21 hours ago

Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why

Pacific Biosciences of California (PACB) closed at $1.68 in the latest trading session, marking a -2.89% move from the prior …

Impact on PACB: Potentially positive price action expected

Analysis of stock market developments showing bullish sentiment. Medium (60%)

View full analysis →

Yahoo Finance 60% confidence

Economy

3 months, 1 week ago

Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know

A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial …

Impact on PACB: The decline in these stocks, particularly in the healthcare and biotech sectors, …

Shares of Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna plummeted in the afternoon session … High (80%)

View full analysis →

Yahoo Finance 80% confidence